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 Aim: To investigate whether changes in plasma free fatty acid (FFA) composition, as a result of dietary 
intervention, correspond to changes in insulin sensitivity. 
Methods: The RISCK study was a 6-month randomised controlled dietary intervention study, which 
assessed the effect of modifying type of dietary fat and the glycaemic index (GI) of carbohydrates on insulin 
sensitivity.  Fasting plasma FFA profiles and an insulin sensitivity index (Si), derived from intravenous 
glucose tolerance minimal-model analysis, were available from 533 participants, all at elevated risk of Type 
2 diabetes. Bivariate correlations between changes in plasma saturated fatty acids (SFA), monounsaturated 
fatty acids (MUFA) (as a percentage of total plasma FFA) and changes in Si were assessed according to 
treatment group.  Changes in dietary glycaemic index were adjusted for. 
Results:  Increasing total plasma FFA was associated with worsening Si (r=-0.152, P=0.001).  In the high 
MUFA/low GI diet study group, change in MUFA (% of total plasma FFA) was positively associated with 
change in Si (r=0.297, P=0.002).  This association remained significant after adjusting for change in GI.  
Among MUFAs, change in oleic acid (18:1) was most strongly correlated with change in Si (r=0.266, 
P=0.005), as was change in minor plasma FFAs 22:1 (r=0.244, P=0.011) and 17:1 (r=0.196, P=0.042).  In 
the high SFA/high GI diet study group, change in plasma SFAs was not significantly associated with change 
in Si. 
Conclusion: Increasing the proportion of monounsaturated plasma FFAs as a result of dietary intervention 
may confer modest benefit for insulin sensitivity. 
 
 
 
 
 
 
  
Introduction 
Type 2 Diabetes Mellitus (T2DM) is a significant cause of morbidity and mortality and prevalence of the 
disease is anticipated to increase dramatically as a result of the obesity epidemic (1).   There is substantial 
evidence that energy dense, high fat diets are diabetogenic and dietary modification targeted at reducing 
total energy and fat intake is an effective strategy in the prevention of T2DM, with superior outcomes to 
pharmacological interventions (2,3).  However there is uncertainty regarding the effect of modifying dietary 
fat composition on insulin sensitivity.      
 
Results from randomised trials have suggested that substituting saturated fat for unsaturated fat improves 
insulin sensitivity (4,5).  However a recent randomised intervention study failed to demonstrate any benefit 
of reducing dietary saturated fat in a in weight-stable obese European population with the metabolic syndrome (6). 
Thus the optimum dietary approach with regard to fat and T2DM prevention remains unclear.  There is also 
evidence that individual FFAs influence insulin sensitivity both positively and negatively, and to different  
(ref) (7).   However it is currently unclear to what extent dietary fatty acid composition may affect one’s 
propensity to developing impaired glucose tolerance through changes in insulin sensitivity. 
 
To provide evidence based nutritional guidelines on dietary fat and T2DM prevention, controlled 
intervention studies are required.  RISCK was a large intervention study, which manipulated dietary fat and 
carbohydrate composition in free-living individuals (8,9).  The composition of plasma free fatty acids 
(FFAs) reflects dietary fat intake (10).  It follows that any beneficial or harmful effects of individual plasma 
FFAs on insulin sensitivity should be modifiable by diet.  Initial results from the RISCK study indicated that 
iso-energetic replacement of dietary saturated fat with monounsaturated fat had no effect on insulin 
sensitivity (11).   However it has not been considered whether changes in the proportion of individual 
plasma saturated fatty acids (SFA) and monounsaturated fatty acids (MUFA) were associated with changes 
in Si.  We aimed to investigate whether changes in the plasma FFAcomposition, as a result of the dietary 
interventions implemented in the RISCK study, correspond to changes in insulin sensitivity.   
 
  
 Method  
 
RISCK was a large randomised controlled dietary intervention study conducted across five leading U.K. 
nutritional research centres (Reading, Imperial, Surrey, Cambridge and Kings).  The study was performed in 
free-living participants at elevated risk of metabolic disease, and assessed the effect of modifying type of 
dietary fat and the glycaemic index of carbohydrate on metabolic risk factors.  The study design has been 
described in full elsewhere (8,11). 
 
Subjects 
Men and women aged 30-70 who met selection criteria (supplementary table 2) were recruited from the 
general population. Participants were screened to identify individuals at increased metabolic risk but below a 
level warranting clinical intervention.   
 
Study design 
720 participants were enrolled and randomised to five dietary intervention groups by a computerised system 
designed to balance age, sex, waist measurement and HDL cholesterol between groups (supplementary table 
1).  548 participants completed the study (23.9% dropout rate).  The study provided isoenergetic dietary 
substitutions for fat and carbohydrate rich foods while allowing subjects to eat ad libitum.   Key 
exchangeable sources of dietary fat (cooking oils, spreads and margarine) and carbohydrates (e.g. pasta, rice, 
bread, cereal) were substituted for study foods with measured FA profiles and glycaemic indices.  In order 
that diets were isocaloric, carbohydrate levels were modified to ensure the changes to fat intake were 
balanced by carbohydrate intake.  
 
All subjects received the high-SFA and high glycaemic index (HS/HGI) reference diet for a four-week 
run-in period, which represented the average UK diet (~18% saturated fat; GI of 63).  After a run-in period 
baseline measurements were performed and one of the five trial diets prescribed for 24-weeks.  The food 
exchange model successfully achieved the targets for dietary fat and carbohydrate in each of the five 
diets(9). 
 
At the beginning and end of the dietary intervention baseline characteristics were assessed.   Fasting blood 
samples were collected for plasma FFA profiles and a short intravenous glucose tolerance test (IVGTT) 
performed from which insulin sensitivity index (Si) was derived via minimal modelling. FFA concentrations 
were assessed with an enzymatic colorimetry  assay.   
 
Data analysis 
 
Statistical analysis was performed with IBM SPSS statistics software.  Correlations are presented as 
Pearsons’s r values along with corresponding P-values. Si results were assigned standardized values.  
Results with z-score > ±3.3 were defined as outliers (12) and removed from analysis.  
 
Bivariate correlations of baseline (post run-in period) total plasma FFA concentration, total saturated, 
unsaturated, monounsaturated), polyunsaturated (PUFA), omega-3 (n-3) PUFA, and omega-6 (n-6) PUFA 
and Si were assessed for the whole cohort and within individual treatment groups.   
 
Previous work has confirmed that compared to the other intervention groups, RISCK study subjects who 
consumed high MUFA (HM) diets had significantly elevated plasma MUFA levels following the 
intervention (9).  The association between change in the percentage of the total FFA pool comprising of total 
MUFAs and change in Si was assessed both for all subjects receiving HM diets and for the two individual 
HM sub-groups (high monounsaturated fat, high GI [HM/HGI] and high monounsaturated fat, low GI 
[HM/LGI]).  The association between change in percentage of individual MUFAs and change in Si was also 
assessed within this group.  Partial correlations were performed to adjust for change in GI between run-in 
and post intervention to assess the unique effect of the change in MUFA concentration on Si.  Additionally 
linear regression was performed to adjust for age, sex, ethnicity and for % change in body mass across the 
study period.    β co-efficients, where reported, are standardised. When changes in individual fat subtypes 
have been assessed against change in Si, changes in other subgroups were controlled for except for where 
the variables were excessively co-linear.  
Results 
 
Subjects 
Of the 549 participants who completed the RISCK study, IVGTT results and FFA profiles were available for 
533.  Subjects’ baseline characteristics are shown in table 1.  
 
Total plasma FFA concentration at baseline was inversely correlated with Si (r= -0.108, P= 0.013).  Total 
saturated FFA was also inversely associated with Si (r=-0.106, P=0.014) as were total unsaturated FFA (r=-
0.088, P=0.042), total PUFA (r=-0.098, P=0.041) and n-6 PUFA (r=-0.093, P=0.032). There was no 
association between total MUFA or n-3 PUFA and Si. 
 
Change in total plasma FFA concentration across the study period within the whole cohort was inversely 
associated with Si (r=-0.152, P=0.001).  In the high saturated fat (SF) group, changes in SFA (%FFAtotal) 
was not associated with a change in Si.  However in high MUFA groups, increases in % plasma MUFA was 
associated with positive changes in Si (r=0.218, P=0.001).  This remained significant when adjusting for 
change in dietary GI (r=0.212, P=0.003).  When a linear regression model adjusting for age, sex, ethnicity 
and change in body weight was applied this remained significant (β=0.233, P=0.001). When high MUFA 
groups were separated into HM/HGI and HM/LGI groups the association with increasing Si was only 
significant in the low GI group (r=0.297, P=0.002).  After controlling for change in GI, this association 
remained significant (r=0.303, P=0.002).  The relationship also remained after adjustment for age, sex, 
ethnicity and change in body weight (β=0.321, P=0.001) 
 
In the HM groups, change in oleic (18:1) was most strongly positively correlated with change in Si 
(r=0.204, P=0.003), as was change in minor plasma MUFAs 22:1 (r=0.180, P=0.008) 18:1 (r=0.150, 
P=0.035) and 17:1 (r=0.145, P=0.035).  Similarly in the HM/LGI group, change in oleic acid (18:1) was 
most strongly correlated with change in Si (r=0.266, P=0.005), as was 22:1 (r=0.244, P=0.011) and 17:1 
(r=0.196, P=0.042).  These associations remained significant after adjustment for change in GI.   
 
No association was observed between change palmitoleic acid and change in Si when HM groups were 
considered together or individually.  It may also be noted that within HM groups, change in total SFA and 
PUFA (%total FFA) were positively associated with change in Si (r=0.184, P=0.007; r=0.208, P=0.002 
respectively). However, the positive relationship between percentage change in MUFA (%total FFA) and 
change in Si remained when the effects of change in SFA (%total FFA) was controlled for (table 2).  The 
effect of changes in PUFA concentrations of Si could not be accurately controlled for due to excessive co-
linearity with MUFA concentration. 
  
 Discussion 
Original analysis of data from the RISCK study indicated that replacement of dietary saturated fat with 
monounsaturated fat as a result of dietary intervention did not result in a significant improvement in insulin 
sensitivity (11).  However it has not previously been considered how changes in biochemical markers of 
adherence to the dietary interventions, such as changes in the proportion of FFA subclasses, may correspond 
to changes in insulin sensitivity.  Our re-assessment of the RISCK dataset suggest that increasing the 
proportion of the plasma fatty acid pool comprising monounsaturated fatty acids (most notably oleic acid) 
following adherence to a high MUFA dietary intervention may be associated with a modest improvement in 
insulin sensitivity.    
 
There is conflicting evidence from randomised controlled trials on the effect of dietary fat composition on 
Si, and the potential benefits of high MUFA diets. The KANWU study, a 3-month dietary intervention study 
similar in design to RISCK, noted improvements in Si following a reduction in the proportion of dietary 
saturated FFA and a corresponding increases in MUFA (5).  A finding replicated by a smaller intervention 
study that compared the effects of a high MUFA diet and high SF diet on Si (4) but not by the original 
results of the RISCK study or another large pan-European dietary intervention study, LIPGENE, that 
reported no effect on Si following isoenergetic replacement of high SF diets with high MUFA or low 
fat/high carbohydrate diets (6). .  This highlights the current uncertainty regarding the optimal dietary 
strategy for T2DM prevention. 
 
Previous studies have suggested a link between high saturated fat diets (and serum SFA content) and 
increased progression to impaired fasting glycaemia and T2DM  (13 14) .  However there is also evidence 
that individual SFAs differentially influence insulin sensitivity (ref7).  A recent large scale cohort study 
found that individual SFAs were associated both positively and negatively with incidence of T2DM 
(Forouhi et al).  This further suggests it may be an oversimplication to consider an entire FA subclass as 
protective or deleterious with respect to T2DM risk and demonstrates the importance of considering the 
individual effects of FFAs.  At baseline there was a weak inverse association between total saturated fat 
concentration and Si, consistent with the literature.  While there was an inverse correlation between baseline 
total omega-6 PUFA and Si in the RISCK dataset this finding is less consistent with the literature that 
suggests a diet lacking essential n-6 PUFAs such as linoleic acid may promote insulin resistance (15) . 
Dietary intervention studies with sustained high PUFA consumption are required to establish the metabolic 
effects of PUFA on Si. 
 
The fact that total, saturated and unsaturated FFA concentration at baseline were inversely correlated 
suggests that, regardless of fat type, if total consumption (and therefore plasma fat concentration) increases 
beyond a point, insulin sensitivity deteriorates, as is the consensus view.   Interestingly, the KANWU study 
only reported an improvement in insulin sensitivity following substitution of SF for MUFA when fat 
consumption contributed <37% of total energy intake (5).  This would imply that provided fat consumption 
is kept within recommended limits, manipulation of dietary fat type to ensure higher proportions of fat 
subgroups, such as MUFAs, may benefit insulin sensitivity.  Modification of dietary fat quality as opposed 
to quantity may be a more achievable strategy at a public health level given that current efforts aimed at 
reducing total fat consumption have been widely unsuccessful. 
 
The optimal dietary strategy for prevention of T2DM with regard to fat consumption remains uncertain.  Our 
data suggests a modest benefit of increasing the proportion of dietary monounsaturated fat (most 
significantly the major MUFA, oleic acid) on insulin sensitivity.  Longer-term interventions would be 
required to assess the absolute risk reductions for T2DM in populations adhering to this characteristically 
‘Mediterranean’ dietary model, replete in MUFA sources such as olive oil.  On the basis of current evidence 
however, dietary recommendations for T2DM prevention are likely to mirror those for cardiovascular 
disease prevention; reducing total saturated fat intake to <10% and substituting saturated fat sources for 
unsaturated fats where possible  (16) . 
 
The strength of this data is that changes in Si have been assessed against changing FFA levels following a 
long (6 month) intervention period.  A limitation of this analysis is that causality cannot be assumed on the 
basis of correlation.  Furthermore data on physical activity was unavailable; hence the effects of exercise on 
FFA levels could not be adjusted for.  Since the study was conducted solely in individuals at elevated 
metabolic risk generalizability is limited.  However the effects of FFAs and dietary modification in T2DM 
prevention are most pertinent in this high-risk group.  
 
Progression from euglycemia to T2DM is usually a gradual process over time of β-cell dysfunction and of 
declining insulin sensitivity.  Small dietary changes over many years may confer substantial benefit in 
slowing this progression.  At a population level, substituting ‘high risk’ sources of dietary fat for those that 
may have a small protective effect, such as monounsaturated fatty acids, may help to combat the rapid rise 
in T2DM prevalence.   
 
 
 
 
 
 
 
 
  
 Table 1 
 
Characteristic 
 
M (n=227) 
 
 
F (n=306) 
 
Age (y) 
 
53.1  (10.3) 
 
51.9 (9.5) 
 
Ethnicity [n (%)] 
    White 
    South/SE Asian 
    Black 
    Far East 
    Other 
 
   
  187 (87.2) 
  21 (9.3) 
  12 (5.3) 
  1 (0.4) 
  4 (1.8) 
 
 
236 (77.1) 
31 (10.1) 
28 (9.2) 
2 (0.7) 
7 (2.3) 
 
BMI (kg/m
2
) 
 
28.5 (3.8) 
 
28.8 (5.3) 
 
Waist (cm) 
 
102.2 (10.4) 
 
94.2 (12.1) 
 
Average Insulin  (pmol/L) 
 
68.4 (32.0) 
 
63.1 (29.5) 
 
Average Glucose (mmol/L) 
 
5.7 (0.5) 
 
5.5 (0.6) 
 
Insulin sensitivity (x10
-4
 mL∙μU-1∙min-1)4 
 
2.9 (1.9) 
 
3.3 (2.1) 
 
AIRg (mL∙μU-1∙min-1)7 
 
489.4 (364.5) 
 
466.5 (339.5) 
 
Systolic Blood Pressure (mmHg) 
 
134.3 (15.1) 
 
125.5 (15.3) 
 
Diastolic Blood Pressure (mmHg) 
 
82.5 (9.0) 
 
77.4 (9.0) 
 
Total Cholesterol (mmol/L) 
 
5.5 (0 .9) 
 
5.6 (1.0) 
 
HDL Cholesterol (mmol/L) 
 
1.3  (0.3) 
 
1.5 (0.4) 
 
Triglyceride (mmol/L) 
 
1.7 (0.8) 
 
1.4 (0.6) 
 
Smokers [n (%)] 
 
17 (7.5) 
 
16 (5.2) 
 
Anti-hypertensive medication [n (%)] 
 
44 (19.4) 
 
51 (16.7) 
 
HRT [n (%)] 
 
- 
 
34 (11.1) 
 
Oral contraceptive [n (%)] 
 
- 
 
10 (3.3) 
 
Thyroxine [n (%)] 
 
2 (0.9) 
 
22 (7.2) 
 
 
 
 
  
Table 2 – linear regression models 
 
 
Group 
 
Dependent 
variable 
 
 
Independent 
variable 
 
Control 
variables 
 
β 
coefficient 
 
Standard 
error 
 
Standardized  
β coefficient 
 
R
2 
 
R
2
change
 
 
 
P-
value 
HM Si Change in 
MUFA % 
total FFA 
Age, sex, 
ethnicity, 
change in 
bodyweight 
 
0.040 
 
0.012 
 
0.233 0.041 
 
0.054 
 
0.001 
 
HM/LGI Si Change in 
MUFA % 
total FFA 
Age, sex, 
ethnicity, 
change in 
bodyweight 
 
0.059 
 
0.017 
 
0.321 
 
0.094 
 
0.099 
 
0.001 
 
HM 
 
Si 
 
Change in 
MUFA (% 
total FFA) 
 
Change in 
SFA (% 
total FFA) 
 
0.085 
 
0.036 
 
0.475 
 
0.034 
 
0.025 
 
0.020 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary table 1 – Dietary regimes and targets for fat and carbohydrate consumption as a percentage 
of total energy intake. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary table 2 
 
 
 
 
 
 
 
Point system for selection of subjects at elevated risk of metabolic disease: 
Fasting glucose concentration >5.5 mmol/L or insulin concentration >40 pmol/L = 3 points; body mass 
index (BMI; in kg/m
2
) >30 or waist >102 cm for men and >88 cm for women = 2 points; BMI of 25–30 
or waist >94 cm for men and >80 cm (women) = 1 point; treated hypertension = 2 points; systolic BP 
>140 mm Hg = 1 point; diastolic BP >90 mm Hg = 1 point; HDL cholesterol concentration <1.0 
mmol/L for men and <1.3 mmol/L for women = 2 points; and serum triacylglycerol concentration >1.3 
mmol/L = 1 point (11). A score of ≥ 4 qualified entry into the study.   
 
 
Exclusion criteria 
The exclusion criteria for recruitment of participants to RISCK were as follows: history of ischemic 
heart disease; 10-year CVD risk >30%; diabetes mellitus, cancer, pancreatitis, cholestatic liver disease, 
renal disease; use of lipid lowering medication; systemic corticosteroids, androgens, phenytoin, 
erythromycin, drugs for regulation of haemostasis (excluding aspirin); exposure to an investigational 
agent ≤30 days prior to the study; gastrointestinal disorders or use of drugs affecting gastrointestinal 
motility/absorption; history of alcoholism or substance misuse; current or planned pregnancy or birth in 
past 12 months; allergy to or intolerance of intervention foods; unwillingness to adhere to study protocol 
or to provide informed consent; weight change of >3kg in the two months before the study; intake of 
>1g eicosapentanoic acid and docosahexaenoic acid/acids; smoking >20 cigarettes per day (11). 
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